Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
A retrovirus belonging to the family of recently discovered human T-cell leukemia viruses (HTLV), but clearly distinct from each previous isolate, has been isolated from a Caucasian patient with signs and symptoms that often precede the acquired immune deficiency syndrome (AIDS). This virus is a typical type-C RNA tumor virus, buds from the cell membrane, prefers magnesium for reverse transcriptase activity, and has an internal antigen (p25) similar to HTLV p24. Antibodies from serum of this patient react with proteins from viruses of the HTLV-I subgroup, but type-specific antisera to HTLV-I do not precipitate proteins of the new isolate. The virus from this patient has been transmitted into cord blood lymphocytes, and the virus produced by these cells is similar to the original isolate. From these studies it is concluded that this virus as well as the previous HTLV isolates belong to a general family of T-lymphotropic retroviruses that are horizontally transmitted in humans and may be involved in several pathological syndromes, including AIDS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“About two and a half years later, the virus now known as HIV was isolated from an AIDS patient in France, again with its RT as the definitive piece of evidence for its retroviral identity (106).”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [106]
Citations
Cites
Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., & Gallo, R. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7415 · Cited by 5,043
Morbidity and Mortality Weekly Report
(2011) · Wilderness & Environmental Medicine · doi:10.1016/j.wem.2010.11.007 · Cited by 3,423
Kalyanaraman, V. S., Sarngadharan, M. G., Robert-Guroff, M., Miyoshi, I., Blayney, D., Golde, D., & Gallo, R. C. (1982) · Science · doi:10.1126/science.6981847 · Cited by 1,196
Isolation and Transmission of Human Retrovirus (Human T-Cell Leukemia Virus)
Popovic, M., Sarin, P. S., Robert-Gurroff, M., Kalyanaraman, V. S., Mann, D., Minowada, J., & Gallo, R. C. (1983) · Science · doi:10.1126/science.6600519 · Cited by 559
Immunologic abnormalities in homosexual men
Stahl, R. E., Friedman-Kien, A., Dubin, R., Marmor, M., & Zolla-Pazner, S. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90174-7 · Cited by 318
Robert-Guroff, M., Ruscetti, F. W., Posner, L. E., Poiesz, B. J., & Gallo, R. C. (1981) · The Journal of experimental medicine · doi:10.1084/jem.154.6.1957 · Cited by 260
Kalyanaraman, V. S., Sarngadharan, M. G., Poiesz, B., Ruscetti, F. W., & Gallo, R. C. (1981) · Journal of Virology · doi:10.1128/jvi.38.3.906-915.1981 · Cited by 235
DOES PREGNANCY PROTECT AGAINST OVARIAN CANCER?
Beral, V., Fraser, P., & Chilvers, C. (1978) · The Lancet · doi:10.1016/s0140-6736(78)90925-x · Cited by 191
de microbiologie., S. F. (1915) · Cited by 167
Karess, R. E., Hayward, W. S., & Hanafusa, H. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.7.3154 · Cited by 128
Research works printed but not linked: 7
- NEW ENGLAND JOURNAL OF MEDICINE 306: 248 (1982).
- FANNIN, S, MMWR 31: 305 (1982).
- MARMOR, M, RISK-FACTORS FOR KAPOSIS SARCOMA IN HOMOSEXUAL MEN, LANCET 1: 1083 (1982).
- MILDVAN, D, MORBIDITY AND MORTALITY WEEKLY REPORT 31: 249 (1982).
- OREILLY, R, MORBIDITY AND MORTALITY WEEKLY REPORT 31: 665 (1982).
- POON, M.C., MORBIDITY AND MORTALITY WEEKLY REPORT 31: 644 (1982).
- ROZENBAUM, W, MULTIPLE OPPORTUNISTIC INFECTION IN A MALE-HOMOSEXUAL IN FRANCE, LANCET 1: 572 (1982).
Cited by
Items 201–300 of 316
LINNAEUS: A species name identification system for biomedical literature
Gerner, M., Nenadic, G., & Bergman, C. M. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-85 · Cited by 335
Primary Human T-Lymphotropic Virus Type III Infection
HO, D. D., SARNGADHARAN, M. G., RESNICK, L., DIMARZOVERONESE, F., ROTA, T. R., & HIRSCH, M. S. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-6-880 · Cited by 334
Darlix, J.-L., Gabus, C., Nugeyre, M.-T., Clavel, F., & Barré-Sinoussi, F. (1990) · Journal of Molecular Biology · doi:10.1016/0022-2836(90)90392-y · Cited by 333
Self-citationPast, present and future: 30 years of HIV research
Barré-Sinoussi, F., Ross, A. L., & Delfraissy, J.-F. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3132 · Cited by 332
Self-citationThe spread of HIV-1 in Africa: sexual contact patterns and the predicted demographic impact of AIDS
Anderson, R. M., May, R. M., Boily, M. C., Garnett, G. P., Rowley, J. T., & May, R. M. (1991) · Nature · doi:10.1038/352581a0 · Cited by 329
Immunopathogenesis of the Acquired Immunodeficiency Syndrome
BOWEN, D. L., LANE, H. C., & FAUCI, A. S. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-5-704 · Cited by 328
Angiogenic Properties of Kaposi's Sarcoma-Derived Cells After Long-Term Culture in Vitro
Salahuddin, S. Z., Nakamura, S., Biberfeld, P., Kaplan, M. H., Markham, P. D., Larsson, L., & Gallo, R. C. (1988) · Science · doi:10.1126/science.2459779 · Cited by 327
Mechanism of action of regulatory proteins encoded by complex retroviruses
Cullen, B. R. (1992) · Microbiological Reviews · doi:10.1128/mmbr.56.3.375-394.1992 · Cited by 324
Horowitz, B., Wiebe, M. E., Lippin, A., & Stryker, M. H. (1985) · Transfusion · doi:10.1046/j.1537-2995.1985.25686071422.x · Cited by 324
Molecular cloning and characterization of the HTLV-III virus associated with AIDS
Hahn, B. H., Shaw, G. M., Arya, S. K., Popovic, M., Gallo, R. C., & Wong-Staal, F. (1984) · Nature · doi:10.1038/312166a0 · Cited by 324
An Integrated Overview of HIV-1 Latency
Ruelas, D. S., & Greene, W. C. (2013) · Cell · doi:10.1016/j.cell.2013.09.044 · Cited by 324
Rosen, C. A., Sodroski, J. G., Goh, W. C., Dayton, A. I., Lippke, J., & Haseltine, W. A. (1986) · Nature · doi:10.1038/319555a0 · Cited by 323
HTLV-III in the Semen and Blood of a Healthy Homosexual Man
Ho, D. D., Schooley, R. T., Rota, T. R., Kaplan, J. C., Flynn, T., Salahuddin, S. Z., Gonda, M. A., & Hirsch, M. S. (1984) · Science · doi:10.1126/science.6208608 · Cited by 322
Occupational Risk of the Acquired Immunodeficiency Syndrome among Health Care Workers
McCray, E., & The Cooperative Needlestick Surveillance Group* (1986) · New England Journal of Medicine · doi:10.1056/nejm198604243141729 · Cited by 320
Transmission of HTLV-III Infection from Human Plasma to Chimpanzees: An Animal Model for AIDS
Alter, H. J., Eichberg, J. W., Masur, H., Saxinger, W. C., Gallo, R., Macher, A. M., Lane, H. C., & Fauci, A. S. (1984) · Science · doi:10.1126/science.6093251 · Cited by 319
Folks, T., Benn, S., Rabson, A., Theodore, T., Hoggan, M. D., Martin, M., Lightfoote, M., & Sell, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.13.4539 · Cited by 318
A molecular clone of HTLV-III with biological activity
Fisher, A. G., Collalti, E., Ratner, L., Gallo, R. C., & Wong-Staal, F. (1985) · Nature · doi:10.1038/316262a0 · Cited by 316
Intrafamilial Transmission of Adult T Cell Leukemia Virus
Kajiyama, W., Kashiwagi, S., Ikematsu, H., Hayashi, J., Nomura, H., & Okochi, K. (1986) · Journal of Infectious Diseases · doi:10.1093/infdis/154.5.851 · Cited by 314
Site-specific mutagenesis of AIDS virus reverse transcriptase
Larder, B. A., Purifoy, D. J. M., Powell, K. L., & Darby, G. (1987) · Nature · doi:10.1038/327716a0 · Cited by 312
Mervis, R. J., Ahmad, N., Lillehoj, E. P., Raum, M. G., Salazar, F. H., Chan, H. W., & Venkatesan, S. (1988) · Journal of Virology · doi:10.1128/jvi.62.11.3993-4002.1988 · Cited by 310
RECOMBINANT HUMAN INTERFERON ALFA-A SUPPRESSES HTLV-III REPLICATION IN VITRO
Ho, D., Rota, T., Kaplan, J., Hartshorn, K., Andrews, C., Schooley, R., & Hirsch, M. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92144-0 · Cited by 305
Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity
Chesebro, B., & Wehrly, K. (1988) · Journal of Virology · doi:10.1128/jvi.62.10.3779-3788.1988 · Cited by 304
Barat, C., Lullien, V., Schatz, O., Keith, G., Nugeyre, M. T., Grüninger-Leitch, F., Barré-Sinoussi, F., LeGrice, S. F., & Darlix, J. L. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08488.x · Cited by 303
Self-citationProductive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6
Lusso, P., Ensoli, B., Markham, P. D., Ablashi, D. V., Salahuddin, S. Z., Tschachler, E., Wong-Staal, F., & Gallo, R. C. (1989) · Nature · doi:10.1038/337370a0 · Cited by 303
Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus
Mosca, J. D., Bednarik, D. P., Raj, N. B. K., Rosen, C. A., Sodroski, J. G., Haseltine, W. A., & Pitha, P. M. (1987) · Nature · doi:10.1038/325067a0 · Cited by 303
Luciw, P. A., Cheng-Mayer, C., & Levy, J. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1434 · Cited by 303
Stein, D. S., Korvick, J. A., & Vermund, S. H. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/165.2.352 · Cited by 302
EYSTER, M. E., GAIL, M. H., BALLARD, J. O., AL-MONDHIRY, H., & GOEDERT, J. J. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-1-1 · Cited by 301
Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS)
Kaplan, M. H., Sadick, N., Scott McNutt, N., Meltzer, M., Sarngadharan, M. G., & Pahwa, S. (1987) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(87)70066-8 · Cited by 301
Bagasra, O., Hauptman, S. P., Lischner, H. W., Sachs, M., & Pomerantz, R. J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205213262103 · Cited by 300
Human immunodeficiency virus can productively infect cultured human glial cells.
Cheng-Mayer, C., Rutka, J. T., Rosenblum, M. L., McHugh, T., Stites, D. P., & Levy, J. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3526 · Cited by 297
Human immunodeficiency virus infection of CD4-bearing cells occurs by a pH-independent mechanism
McClure, M. O., Marsh, M., & Weiss, R. A. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02839.x · Cited by 295
HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus
Trono, D., Feinberg, M. B., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90874-x · Cited by 296
The history and challenge of HIV prevention
Merson, M. H., O'Malley, J., Serwadda, D., & Apisuk, C. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60884-3 · Cited by 296
Risk to Human Health from a Plethora of Simian Immunodeficiency Viruses in Primate Bushmeat
Peeters, M., Courgnaud, V., Abela, B., Auzel, P., Pourrut, X., Bibollet-Ruche, F., Loul, S., Liegeois, F., Butel, C., Koulagna, D., et al. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0805.01-0522 · Cited by 296
INACTIVATION OF LYMPHADENOPATHY-ASSOCIATED VIRUS BY HEAT, GAMMA RAYS, AND ULTRAVIOLET LIGHT
Spire, B., Barré-Sinoussi, F., Dormont, D., Montagnier, L., & Chermann, J. C. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92026-4 · Cited by 295
Self-citationPrevention of transfusion-transmitted infections
Busch, M. P., Bloch, E. M., & Kleinman, S. (2019) · Blood · doi:10.1182/blood-2018-11-833996 · Cited by 294
Ho, D. D., Sarngadharan, M. G., Hirsch, M. S., Schooley, R. T., Rota, T. R., Kennedy, R. C., Chanh, T. C., & Sato, V. L. (1987) · Journal of Virology · doi:10.1128/jvi.61.6.2024-2028.1987 · Cited by 294
Coming Full Circle—From Endless Complexity to Simplicity and Back Again
Weinberg, R. A. (2014) · Cell · doi:10.1016/j.cell.2014.03.004 · Cited by 294
Garcia, J. A., Wu, F. K., Mitsuyasu, R., & Gaynor, R. B. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02711.x · Cited by 293
New Human T-Lymphotropic Retrovirus Related to Simian T-Lymphotropic Virus Type III (STLV-III AGM )
Kanki, P. J., Barin, F., M'Boup, S., Allan, J. S., Romet-Lemonne, J. L., Marlink, R., McLane, M. F., Lee, T.-H., Arbeille, B., Denis, F., et al. (1986) · Science · doi:10.1126/science.3006256 · Cited by 293
Sullivan, N., Sun, Y., Sattentau, Q., Thali, M., Wu, D., Denisova, G., Gershoni, J., Robinson, J., Moore, J., & Sodroski, J. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.4694-4703.1998 · Cited by 292
Helseth, E., Olshevsky, U., Furman, C., & Sodroski, J. (1991) · Journal of Virology · doi:10.1128/jvi.65.4.2119-2123.1991 · Cited by 292
Sullivan, N., Sun, Y., Li, J., Hofmann, W., & Sodroski, J. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4413-4422.1995 · Cited by 292
Identification of a protein encoded by the vpu gene of HIV-1
Cohen, E. A., Terwilliger, E. F., Sodroski, J. G., & Haseltine, W. A. (1988) · Nature · doi:10.1038/334532a0 · Cited by 292
De Rocquigny, H., Gabus, C., Vincent, A., Fournié-Zaluski, M. C., Roques, B., & Darlix, J. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6472 · Cited by 289
Farzan, M., Choe, H., Martin, K., Marcon, L., Hofmann, W., Karlsson, G., Sun, Y., Barrett, P., Marchand, N., Sullivan, N., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.3.405 · Cited by 289
Coates, J. A., Cammack, N., Jenkinson, H. J., Mutton, I. M., Pearson, B. A., Storer, R., Cameron, J. M., & Penn, C. R. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.1.202 · Cited by 288
Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs
Coiras, M., López-Huertas, M. R., Pérez-Olmeda, M., & Alcamí, J. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2223 · Cited by 288
HTLV-III gag Protein Is Processed in Yeast Cells by the Virus pol -Protease
Kramer, R. A., Schaber, M. D., Skalka, A. M., Ganguly, K., Wong-Staal, F., & Reddy, E. P. (1986) · Science · doi:10.1126/science.2420008 · Cited by 287
DETERMINANTS OF RETROVIRUS (HTLV-III) ANTIBODY AND IMMUNODEFICIENCY CONDITIONS IN HOMOSEXUAL MEN
Goedert, J., Biggar, R., Winn, D., Greene, M., Mann, D., Gallo, R., Sarngadharan, M. G., Weiss, S., Grossman, R., Bodner, A., et al. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92624-2 · Cited by 286
Twenty years of therapy for HIV-1 infection
Pomerantz, R. J., & Horn, D. L. (2003) · Nature Medicine · doi:10.1038/nm0703-867 · Cited by 284
AIDS — An Immunologic Reevaluation
Seligmann, M., Chess, L., Fahey, J. L., Fauci, A. S., Lachmann, P. J., L'Age-Stehr, J., Ngu, J., Pinching, A. J., Rosen, F. S., Spira, T. J., et al. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411153112005 · Cited by 284
In Vitro Anti-HIV Activity of Biflavonoids Isolated from Rhus succedanea and Garcinia multiflora
Lin, Y.-M., Anderson, H., Flavin, M. T., Pai, Y.-H. S., Mata-Greenwood, E., Pengsuparp, T., Pezzuto, J. M., Schinazi, R. F., Hughes, S. H., & Chen, F.-C. (1997) · Journal of Natural Products · doi:10.1021/np9700275 · Cited by 284
Henderson, L. E., Bowers, M. A., Sowder, R. C., Serabyn, S. A., Johnson, D. G., Bess, J. W., Arthur, L. O., Bryant, D. K., & Fenselau, C. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.1856-1865.1992 · Cited by 283
St Clair, M. H., Richards, C. A., Spector, T., Weinhold, K. J., Miller, W. H., Langlois, A. J., & Furman, P. A. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.12.1972 · Cited by 281
Garcia, J. A., Harrich, D., Soultanakis, E., Wu, F., Mitsuyasu, R., & Gaynor, R. B. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03437.x · Cited by 280
Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression
Rosenberg, Z. F., & Fauci, A. S. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90070-p · Cited by 280
Tebit, D. M., & Arts, E. J. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70186-9 · Cited by 280
Ribavirin Antagonizes the Effect of Azidothymidine on HIV Replication
Vogt, M. W., Hartshorn, K. L., Furman, P. A., Chou, T.-C., Fyfe, J. A., Coleman, L. A., Crumpacker, C., Schooley, R. T., & Hirsch, M. S. (1987) · Science · doi:10.1126/science.2435003 · Cited by 279
Debouck, C., Gorniak, J. G., Strickler, J. E., Meek, T. D., Metcalf, B. W., & Rosenberg, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.8903 · Cited by 278
Rates and dates of divergence between AIDS virus nucleotide sequences.
(1988) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a040503 · Cited by 278
Nucleoside Analogues as Chemotherapeutic Agents: A Review
Périgaud, C., Gosselin, G., & Imbach, J. L. (1992) · Nucleosides and Nucleotides · doi:10.1080/07328319208021748 · Cited by 277
Current status and challenges of antiretroviral research and therapy
Esté, J. A., & Cihlar, T. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.10.007 · Cited by 277
Saltarelli, M., Querat, G., Konings, D. A. M., Vigne, R., & Clements, J. E. (1990) · Virology · doi:10.1016/0042-6822(90)90303-9 · Cited by 276
Huang, C.-C., Venturi, M., Majeed, S., Moore, M. J., Phogat, S., Zhang, M.-Y., Dimitrov, D. S., Hendrickson, W. A., Robinson, J., Sodroski, J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308527100 · Cited by 275
Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco.
Chaisson, R. E., Moss, A. R., Onishi, R., Osmond, D., & Carlson, J. R. (1987) · American Journal of Public Health · doi:10.2105/ajph.77.2.169 · Cited by 274
The Molecular Biology of Human Immunodeficiency Virus Type 1 Infection
Epstein, F. H., Epstein, F. H., & Greene, W. C. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101313240506 · Cited by 273
NARA, P. L., HATCH, W. C., DUNLOP, N. M., ROBEY, W. G., ARTHUR, L. O., GONDA, M. A., & FISCHINGER, P. J. (1987) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1987.3.283 · Cited by 272
Human immunodeficiency virus long terminal repeat responds to T-cell activation signals.
Tong-Starksen, S. E., Luciw, P. A., & Peterlin, B. M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6845 · Cited by 271
Witvrouw, M., Pannecouque, C., Switzer, W. M., Folks, T. M., Clercq, E. D., & Heneine, W. (2004) · Antiviral Therapy · doi:10.1177/135965350400900115 · Cited by 271
HIV-1 Tat protein trans-activates transcription in vitro
Marciniak, R. A., Calnan, B. J., Frankel, A. D., & Sharp, P. A. (1990) · Cell · doi:10.1016/0092-8674(90)90145-5 · Cited by 270
Kornbluth, R. S., Oh, P. S., Munis, J. R., Cleveland, P. H., & Richman, D. D. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.3.1137 · Cited by 270
Expression and Characterization of the Trans -Activator of HTLV-III/LAV Virus
Wright, C. M., Felber, B. K., Paskalis, H., & Pavlakis, G. N. (1986) · Science · doi:10.1126/science.3490693 · Cited by 269
Geyer, H., Holschbach, C., Hunsmann, G., & Schneider, J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37849-9 · Cited by 267
HIV-1 Reverse Transcriptase Is a Target for Cytotoxic T Lymphocytes in Infected Individuals
Walker, B. D., Flexner, C., Paradis, T. J., Fuller, T. C., Hirsch, M. S., Schooley, R. T., & Moss, B. (1988) · Science · doi:10.1126/science.2451288 · Cited by 267
Chen, Z., Telfier, P., Gettie, A., Reed, P., Zhang, L., Ho, D. D., & Marx, P. A. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.3617-3627.1996 · Cited by 266
Immunoglobulin V H 3 Gene Products: Natural Ligands for HIV gp120
Berberian, L., Goodglick, L., Kipps, T. J., & Braun, J. (1993) · Science · doi:10.1126/science.7690497 · Cited by 263
Retrovirus Envelope Glycoproteins
Hunter, E., & Swanstrom, R. (1990) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-75218-6_7 · Cited by 262
Kanazawa, S., Okamoto, T., & Peterlin, B. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)80159-4 · Cited by 262
Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B
Chen, D.-S. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.01.002 · Cited by 261
ANTI-RETROVIRAL EFFECTS OF INTERFERON-α IN AIDS-ASSOCIATED KAPOSI'S SARCOMA
Clifford Lane, H., Feinberg, J., Davey, V., Deyton, L., Baseler, M., Manischewitz, J., Masur, H., Kovacs, J., Herpin, B., Walker, R., et al. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90811-2 · Cited by 261
Induction of HTLV-III/LAV from a Nonvirus-Producing T-Cell Line: Implications for Latency
Folks, T., Powell, D. M., Lightfoote, M. M., Benn, S., Martin, M. A., & Fauci, A. S. (1986) · Science · doi:10.1126/science.3003906 · Cited by 260
Helseth, E., Kowalski, M., Gabuzda, D., Olshevsky, U., Haseltine, W., & Sodroski, J. (1990) · Journal of Virology · doi:10.1128/jvi.64.5.2416-2420.1990 · Cited by 260
Landesman, S. H., Ginzburg, H. M., & Weiss, S. H. (1985) · New England Journal of Medicine · doi:10.1056/nejm198502213120829 · Cited by 259
Gauduin, M.-C., Parren, P. W. H. I., Weir, R., Barbas, C. F., Burton, D. R., & Koup, R. A. (1997) · Nature Medicine · doi:10.1038/nm1297-1389 · Cited by 258
Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs
Tompa, D. R., Immanuel, A., Srikanth, S., & Kadhirvel, S. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.01.076 · Cited by 257
Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents
Pauwels, R., Balzarini, J., Schols, D., Baba, M., Desmyter, J., Rosenberg, I., Holy, A., & De Clercq, E. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.7.1025 · Cited by 256
Morellet, N., Jullian, N., De Rocquigny, H., Maigret, B., Darlix, J. L., & Roques, B. P. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05377.x · Cited by 256
Novel Therapies Based on Mechanisms of HIV-1 Cell Entry
Kilby, J. M., & Eron, J. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022812 · Cited by 254
Booth, R. E., Kwiatkowski, C. F., & Chitwood, D. D. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00094-0 · Cited by 254
Progressive encephalopathy in children with acquired immue deficiency syndrome
Epstien, L. G., Sharer, L. R., Joshi, V. V., Fojas, M. M., Koenigsberger, M. R., & Oleske, J. M. (1985) · Annals of Neurology · doi:10.1002/ana.410170512 · Cited by 253
Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24
Veronese, F. D., Copeland, T. D., Oroszlan, S., Gallo, R. C., & Sarngadharan, M. G. (1988) · Journal of Virology · doi:10.1128/jvi.62.3.795-801.1988 · Cited by 203
Four decades of HIV/AIDS - much accomplished, much to do
Fauci, A. S., & Lane, H. C. (2020) · New England Journal of Medicine · doi:10.1056/nejmp1916753 · Cited by 199
Neuroleukin: A Lymphokine Product of Lectin-Stimulated T Cells
Gurney, M. E., Apatoff, B. R., Spear, G. T., Baumel, M. J., Antel, J. P., Bania, M. B., & Reder, A. T. (1986) · Science · doi:10.1126/science.3020690 · Cited by 195
Yu, H. J., Reuter, M. A., & McDonald, D. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000134 · Cited by 193
Furfine, E. S., & Reardon, J. E. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52449-2 · Cited by 181
Human RNA “Rumor” Viruses: the Search for Novel Human Retroviruses in Chronic Disease
Voisset, C., Weiss, R. A., & Griffiths, D. J. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00033-07 · Cited by 157
“Virus culture has been of enormous value for human retrovirology, as both HTLV-1 and HIV-1 were first identified in cultured lymphocytes from infected patients (33, 399).”
BackgroundInfluentialFutsch, N., Mahieux, R., & Dutartre, H. (2017) · Viruses · doi:10.3390/v10010001 · Cited by 155
“Human T-cell Leukemia Virus type-1 (HTLV-1) was first described by Robert Gallo’s team in 1980 [1,2], before the discovery of Human Immunodeficiency Virus type-1 (HIV-1) [3].”
BackgroundBiochemical mechanism of HIV-I Vpr function. Specific interaction with a cellular protein.
Zhao, L. J., Mukherjee, S., & Narayan, O. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40719-8 · Cited by 129
Metadata
- Authors
- Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., Rozenbaum, W., & Montagnier, L.
- Affiliations
- Institut Pasteur, Département de Virologie, 75724 Paris Cédex 15
- Institut Pasteur (FR)
- Hôpital Claude Bernard, Laboratoire Central-Virologie, 75019 Paris
- Pitié-Salpêtrière Hospital (FR)
- ORCID
- Rozenbaum, W.
- Venue
- Science
- Published
- 1983-05-20
- Volume
- 220
- Issue
- 4599
- Pages
- 868-871
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1977282539
- Cited by
- 7,038
- References
- 13
- Citations by year
- 2026: 56 · 2025: 77 · 2024: 135 · 2023: 124 · 2022: 130 · 2021: 159 · 2020: 129 · 2019: 141 · 2018: 138 · 2017: 111 · 2016: 146 · 2015: 167 · 2014: 192 · 2013: 193 · 2012: 210
- FWCI
- 141.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- human T-cell leukemia virus, HTLV-1, AIDS, retrovirus isolation, reverse transcriptase, horizontal transmission, cord blood lymphocytes
- MeSH terms
- Chromobox Protein Homolog 5, Acquired Immunodeficiency Syndrome, Adult, Animals, Antibodies, Viral, Cells, Cultured, Humans, Male, Microscopy, Electron, Retroviridae, RNA-Directed DNA Polymerase, T-Lymphocytes, Tumor Virus Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.